Vor Biopharma Inc. has granted stock options to purchase a total of 113,478 shares and restricted stock units (RSUs) representing 24,319 shares of common stock to 20 newly hired employees. The stock options have a ten-year term with an exercise price of $30.22 per share, equal to the closing price on the grant date of October 15, 2025. The options vest over four years: 25% after 12 months and the remainder monthly over the following 36 months. The RSUs also vest over four years, with 25% after 12 months and the remainder vesting quarterly over the next 36 months. Both awards are subject to continued employment and the terms of the company's 2023 Inducement Plan.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9566182-en) on October 31, 2025, and is solely responsible for the information contained therein.